A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 50 to 70 Years
Condition(s):Herpes ZosterLast Updated:March 28, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Herpes ZosterLast Updated:March 28, 2024Not yet recruiting
Condition(s):ARDS, HumanLast Updated:March 20, 2024Recruiting
Condition(s):Food Allergy; Food Allergy in InfantsLast Updated:March 22, 2024Not yet recruiting
Condition(s):Colon Cancer; Model DiseaseLast Updated:February 20, 2024Completed
Condition(s):Osteoarthritis, Knee; OsteoarthritisLast Updated:February 16, 2024Not yet recruiting
Condition(s):Healthy ParticipantsLast Updated:February 6, 2024Not yet recruiting
Condition(s):Healthy Participants; AsthmaLast Updated:March 7, 2024Recruiting
Condition(s):Healthy ParticipantsLast Updated:March 21, 2024Recruiting
Condition(s):Inflammatory Bowel Diseases; Blau Syndrome; Crohn Disease; Ulcerative Colitis; SpondyloarthritisLast Updated:March 4, 2024Recruiting
Condition(s):Healthy ParticipantsLast Updated:March 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.